نتائج البحث - "Viktor Rossiev"

1

دورية أكاديمية

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

المؤلفون: Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, for the PROUD-PV Study Group

المصدر: HemaSphere, Vol 4, Iss 6, p e485 (2020)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://journals.lww.com/10.1097/HS9.0000000000000485; https://doaj.org/toc/2572-9241

URL الوصول: https://doaj.org/article/5fda375d5298471dabb1ce29d4ebc970

View record in Lippincott, Williams & Wilkins View record at Wiley

Full Text Finder

2

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

المؤلفون: Ella Willenbacher, Zita Borbényi, Steffen Koschmieder, Robert Kralovics, Mario Cazzola, Uwe Platzbecker, Emanuil Gheorghita, Pencho Georgiev, Heinz Gisslinger, Mathieu Puyade, Malgorzata Calbecka, Jerome Rey, Kurt Krejcy, Jiri Mayer, Krzysztof Warzocha, Emilie Cayssials-Caylus, Veronika Buxhofer-Ausch, János Jakucs, Anna Vallova, Georgi Mihaylov, Hans Carl Hasselbalch, Lydia Roy, Vera Yablokova, Olga Cerna, Aleksander Skotnicki, Richard Greil, Jiri Schwarz, Vera Stoeva, Lylia Sivcheva, Zvenyslava Masliak, Halyna Pylypenko, Antonia Hatalova, Delia Dima, Jose Miguel Torregrosa-Diaz, Elena Volodicheva, Jean-Jacques Kiladjian, S V Klymenko, Carlos Besses Raebel, Polina Kaplan, Irina Sokolova, Horia Bumbea, Miklos Egyed, Nicoleta Berbec, Barbara Grohmann-Izay, Alexander Myasnikov, Petr Dulicek, Tamila Lysa, Dominik Wolf, Andrei Cucuianu, Christoph Klade, Mihaela Lazaroiu, Maria Soroka-Wojtaszko, Tamás Masszi, Ernst Forjan, Liana Gercheva-Kyuchukova, Franz Bauer, Dorota Krochmalczyk, Árpád Illés, Mikulas Hrubisko, Jolanta Starzak-Gwozdz, Viktor Rossiev

المصدر: The Lancet Haematology. 7:e196-e208

مصطلحات موضوعية: Male, medicine.medical_specialty, Polycythaemia, Equivalence Trials as Topic, Interferon alpha-2, Antiviral Agents, Polyethylene Glycols, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, Stage (cooking), Adverse effect, Polycythemia Vera, Aged, business.industry, Interferon-alpha, Hematology, Middle Aged, Prognosis, medicine.disease, Interim analysis, Recombinant Proteins, Clinical trial, Tolerability, 030220 oncology & carcinogenesis, Female, business, Follow-Up Studies, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef767894c3f5dbd8084e8e09eb738e2f
https://doi.org/10.1016/s2352-3026(19)30236-4

View record from ScienceDirect

Full Text via ClinicalKey

3

Ropeginterferon Alfa-2b versus Standard Therapy for Polycythaemia Vera; a Randomised, Controlled, Phase III Trial

المؤلفون: Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Barbara Grohmann-Izay, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, PROUD-PV Study Group

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: Polycythaemia, medicine.medical_specialty, education.field_of_study, business.industry, Population, Institutional review board, medicine.disease, Tolerability, Internal medicine, Good clinical practice, Clinical endpoint, medicine, education, business, Adverse effect, Disease burden

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::37569d2e3dc4a85c590828407b37f479
https://doi.org/10.2139/ssrn.3426089

4

Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study

المؤلفون: Liana Gercheva-Kyuchukova, Miklos Egyed, Vera Yablokova, Christoph Klade, Viktor Rossiev, Heinz Gisslinger, Halyna Pylypenko, Hans Carl Hasselbalch, Lylia Sivcheva, Petr Dulíček, Kurt Krejcy, Jean-Jacques Kiladjian, Dorota Krochmalczyk, Jiri Mayer, Pencho Georgiev, Robert Kralovics, Árpád Illés

المصدر: Blood. 134:553-553

مصطلحات موضوعية: medicine.medical_specialty, Acute leukemia, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Debulking, Biochemistry, law.invention, Discontinuation, Polycythemia vera, Randomized controlled trial, law, Internal medicine, medicine, Complete Molecular Response, Adverse effect, Myelofibrosis, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0c86d7b21b0f0e43d41dbe1bbfc4760d
https://doi.org/10.1182/blood-2019-122233

5

Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT

المؤلفون: Kurt Krejcy, Petr Dulíček, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Dorota Krochmalczyk, Viktor Rossiev, Christoph Klade, Liana Gercheva-Kyuchukova, Halyna Pylypenko, Robert Kralovics, Hans Carl Hasselbalch, Miklos Egyed, Jean-Jacques Kiladjian, Árpád Illés, Barbara Grohmann-Izay, Heinz Gisslinger, Pencho Georgiev

المصدر: Blood. 132:579-579

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::98b19f2c5bca29244ad29ef63bcc9b05
https://doi.org/10.1182/blood-2018-99-118715

6

Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agent

المؤلفون: Dixie-Lee Esseltine, Paul G. Richardson, Meletios A. Dimopoulos, Martin Kropff, Maria-Victoria Mateos, Kevin Liu, Jian Hou, Marie-Christiane Vekemans, Viktor Rossiev, Helgi van de Velde, Jesús F. San Miguel, Maria Teresa Petrucci, Nuriet K. Khuageva, William Deraedt, Kenneth C. Anderson, Andrew Cakana, Tadeusz Robak, Rudolf Schlag, Ofer Shpilberg

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9591ffd23e1509eb6383d1592474c82
https://doi.org/10.1111/j.1365-2141.2011.08569.x

View record at Wiley

7

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

المصدر: Blood. 124(3)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cyclophosphamide, Chronic lymphocytic leukemia, Immunology, Gene Expression, Biochemistry, Disease-Free Survival, Antibodies, Monoclonal, Murine-Derived, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, RNA, Messenger, RNA, Neoplasm, Proportional Hazards Models, Retrospective Studies, business.industry, Proportional hazards model, Cell Biology, Hematology, medicine.disease, Combined Modality Therapy, Leukemia, Lymphocytic, Chronic, B-Cell, Fludarabine, Leukemia, Focal Adhesion Kinase 1, Monoclonal, Cancer research, Biomarker (medicine), Rituximab, Immunotherapy, business, Vidarabine, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e68a916aff362d3b561594eb8ab2e1
https://pubmed.ncbi.nlm.nih.gov/24916506

8

Effect of FCGR2A and FCGR3A variants on CLL outcome

المصدر: Blood. 116(20)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f972e1479062e8c2a2f4703988128236
https://pubmed.ncbi.nlm.nih.gov/20705761

9

A220 Bortezomib and Melphalan as Part of VMP Are Associated with Similar Hematologic Toxicity to MP Alone

المؤلفون: P. G. Richardson, J. Hou, KC Anderson, H van de Velde, M.A. Dimopoulos, J F San Miguel, Michel Delforge, Martin Kropff, M.T. Petrucci, Rudolf Schlag, Ofer Shpilberg, A Liu, William Deraedt, Nuriet K. Khuageva, Andrew Cakana, Viktor Rossiev, Tadeusz Robak, M.V. Mateos

المصدر: Clinical Lymphoma and Myeloma. 9:S36-S37

مصطلحات موضوعية: Oncology, Melphalan, Cancer Research, medicine.medical_specialty, Bortezomib, business.industry, Hematology, General Medicine, Hematologic toxicity, Internal medicine, medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d2f12e053ad6ece4ce8b3e0c26483591
https://doi.org/10.1016/s1557-9190(11)70507-8

View record from ScienceDirect

10

A217 Erythropoiesis-Stimulating Agents: No Impact on Long-Term Outcome in MM Patients in the VISTA Trial

المؤلفون: M.T. Petrucci, Tadeusz Robak, M.A. Dimopoulos, H van de Velde, William Deraedt, J F San Miguel, P. G. Richardson, Andrew Cakana, Kolosova LIu, Nuriet K. Khuageva, Rudolf Schlag, M.V. Mateos, Michel Delforge, KC Anderson, Martin Kropff, Ofer Shpilberg, J. Hou, Viktor Rossiev

المصدر: Clinical Lymphoma and Myeloma. 9:S35-S36

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Oncology, business.industry, Medicine, Erythropoiesis, Hematology, General Medicine, business, Intensive care medicine, Outcome (game theory), Term (time)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::71a1a328298c1405667ebe8a968a84bf
https://doi.org/10.1016/s1557-9190(11)70505-4

View record from ScienceDirect

تنقيح النتائج